Dosidal · Switzerland
Tygacil 50 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Switzerland |
|---|---|
| Record | ch:authorisation:57431 (version 1) |
| Level | authorisation |
| Pack code | not anchored |
| Identifiers | swissmedic-authorisation: 57431 atc: J01AA12 |
| Source authority | Swissmedic |
| Read date | 2026-11-15T01:25:13Z |
| authorisation status | first_authorisation: 2007-11-30 term: zugelassen valid_until: 9999-12-31 state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| identity | atc: J01AA12 authorisation_number: 57431 form: PULPI holder: Pfizer AG holder_partner_nr: 1001107 it_number: 08.01.5. name: Tygacil 50 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53Z9gw0ZpeYqykfIWebILaFKzD7e68wps97rP0ynjyx1VPV19CW6uOhhMCGxx8zHO5xIzLs7cGxYigqDq1d1YAUQThe signed record is on this page as issued. Keyring and how to check it: https://dosidal-registry.ai/.well-known/jwks.json |
The signed record (DOSE-10060, JSON)
{"as_of":null,"authority":{"id":"57431","name":"Swissmedic","register":"OGD Praeparate"},"fields":{"authorisation_status":{"asserted_by":"node","clock":{"class":"short","expires_at":"2026-11-22T01:25:13Z"},"effective_from":"2007-11-30","read_at":"2026-11-15T01:25:13Z","source":{"published":"2026-10-31","publisher":"Swissmedic (OGD)","url":"https://ogd.swissmedic.cloud/ogd-arzneimittel/Daten/OGD.zip"},"state":"current","value":{"first_authorisation":"2007-11-30","term":"zugelassen","valid_until":"9999-12-31"}},"identity":{"asserted_by":"node","clock":{"class":"long","expires_at":"2027-02-13T01:25:13Z"},"effective_from":"2007-11-30","read_at":"2026-11-15T01:25:13Z","source":{"published":"2026-10-31","publisher":"Swissmedic (OGD)","url":"https://ogd.swissmedic.cloud/ogd-arzneimittel/Daten/OGD.zip"},"state":"current","value":{"atc":"J01AA12","authorisation_number":"57431","form":"PULPI","holder":"Pfizer AG","holder_partner_nr":"1001107","it_number":"08.01.5.","name":"Tygacil 50 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung"}}},"instance":"CH-DOSE-10060","instance_version":"0.1","market":"CH","node":{"door":"https://mcp.dosidal.ai","id":"ch.dose-10060.org"},"notice":"Artificial intelligence makes mistakes. Read the regulator.","produced_at":"2026-11-15T01:25:15Z","record_id":"ch:authorisation:57431","schema_version":"1.0","signature":{"alg":"ES256","canon":"JCS","kid":"dosidal-record-1.9dbf5d53","sig":"Z9gw0ZpeYqykfIWebILaFKzD7e68wps97rP0ynjyx1VPV19CW6uOhhMCGxx8zHO5xIzLs7cGxYigqDq1d1YAUQ"},"standard":"DOSE-10060","standard_version":"1.0","subject":{"anchor":null,"id":"ch:authorisation:57431","identifiers":[{"system":"swissmedic-authorisation","value":"57431"},{"system":"atc","value":"J01AA12"}],"level":"authorisation","relations":[{"id":"ch:presentation:57431-004","rel":"authorisation_of"}]},"supersedes":null,"version":1}